核心技術與產能CORE TECHNOLOGY AND MANUFACTURING

Cell culture is one of the most important technologies for producing biopharma products today.
MVC specializes in cell culture processes and operates Taiwan's first large-scale PIC/S GMP cell culture manufacturing plant to meet the needs for mass production of vaccines.

OUR TECHNOLOGY

OUR TECHNOLOGY

MVC utilizes mammalian cell-culture technology to develop and manufacture viral vaccines.

READ MORE
OUR FACILITY

OUR FACILITY

We operate Taiwan's first multipurpose cell-based facility that complies with PICS/ GMP standards.

READ MORE
WHAT IS A VACCINE

WHAT IS A VACCINE

Vaccine is a biological preparation that improves immunity to a particular disease.

READ MORE

PIPELINE

MVC focuses on global and regional infectious diseases,
and is committed to developing countermeasures for the prevention
and treatment of emerging infectious diseases, including COVID-19 vaccine,
Enterovirus A17 vaccine, and Dengue vaccine.

COVID-19 Vaccine

MVC COVID-19 Vaccine

READ MORE
Enterovirus A71 Vaccine

Envacgen

READ MORE
Influenza Vaccine QIV

MVC FLU Quadrivalent

READ MORE
Dengue Vaccine

Dengue Vaccine

READ MORE
Anti-RSV Biosimilars

Anti-RSV Biosimilars

READ MORE
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree